ヘルペスマーカー検査市場：適応症別、検査タイプ別、用途別-2025-2030年の世界予測

ヘルペスマーカー検査市場は、2023年に4億6,822万米ドルと評価され、2024年には4億9,786万米ドルに達すると予測され、CAGR 6.46%で成長し、2030年には7億2,583万米ドルに達すると予測されています。

単純ヘルペスウイルス（HSV）感染は、生物学的サンプル中のウイルス抗原や抗体を検出する臨床アッセイによって特定・管理されます。ヘルペスマーカー検査の必要性は、世界のHSV感染症の高い有病率、効果的な疾患管理のためのタイムリーで正確な診断の必要性、個別化医療に対する需要の高まりによってもたらされています。アプリケーションは、ヘルスケア施設における日常的な診断業務から、ウイルスの疫学を理解しワクチンを開発することを目的とした研究開発まで多岐にわたる。エンドユーザーは主に病院、診断研究所、研究機関などです。市場成長は、分子検査技術の進歩、性感染症（STI）に対する意識の高まり、ヘルスケア支出の増加といった要因に影響されています。しかし、成長に対する課題としては、高度な診断システムのコストが高いこと、資源の乏しい地域ではポイントオブケア検査が限られていること、STIに関連する社会的烙印が診断を受けることを妨げていることなどが挙げられます。新たなビジネスチャンスは、ヘルスケアのインフラが整備されつつある発展途上地域での検査サービスの拡大や、検査精度の向上と結果までの時間の短縮を目指した研究開発の継続的な取り組みにあります。企業は、遠隔診断のための在宅検査キットやデジタルヘルスプラットフォームの増加傾向を利用することができます。しかし、規制当局の監視や検査結果における高い特異性と感度の必要性は、依然として重要な障壁となっています。この分野におけるイノベーションは、家庭での使用に適したコスト効率の高い迅速結果検査キットの開発と、予測診断と個別化治療計画のための人工知能の統合に焦点を当てることができます。市場競争は中程度から高水準でダイナミックであり、持続的成長のためには戦略的パートナーシップと継続的イノベーションが必要です。全体として、研究開発への的を絞った投資と戦略的な市場拡大戦略が、既存の課題を克服しながら将来の成長機会を活かす鍵となると思われます。

市場力学：急速に進化するヘルペスマーカー検査市場の主要市場インサイトを公開

ヘルペスマーカー検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 人口におけるヘルペス感染の有病率
  • 口腔および性器感染の早期診断と治療に対する意識の高まり
  • ヘルスケア支出の増加とヘルスケアインフラの改善
• 市場抑制要因
  • 熟練者の不足に伴う検査室の不足
• 市場機会
  • 新しく開発されたヘルペス検査キットのイントロダクション
  • ヘルペス感染症を治療するための新規ワクチンの調査活動の増加
• 市場の課題
  • 厳しく時間のかかる承認プロセス

ポーターのファイブフォース：ヘルペスマーカー検査市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ヘルペスマーカー検査市場における外部からの影響の把握

外部マクロ環境要因は、ヘルペスマーカー検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ヘルペスマーカー検査市場における競合情勢の把握

ヘルペスマーカー検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスヘルペスマーカー検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ヘルペスマーカー検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ヘルペスマーカー検査市場における成功への道筋を描く

ヘルペスマーカー検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 人口におけるヘルペス感染の蔓延
    • 口腔および性器感染症の早期診断と治療に対する意識の高まり
    • ヘルスケア費の増加とヘルスケアインフラの改善
  • 抑制要因
    • 研究室の数が限られており、熟練した人材も不足している
  • 機会
    • 新開発のヘルペス検査キットのイントロダクション
    • ヘルペス感染症を治療するための新しいワクチンの調査活動が活発化
  • 課題
    • 厳格で時間のかかる承認プロセス
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ヘルペスマーカー検査市場適応症別

• HSV-1
• HSV-2

第7章 ヘルペスマーカー検査市場テストタイプ別

• 抗体または抗原ベースのキット
• 核酸増幅ベースのキット
• ウイルス培養検査

第8章 ヘルペスマーカー検査市場：用途別

• 臨床
• 調査

第9章 南北アメリカのヘルペスマーカー検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のヘルペスマーカー検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのヘルペスマーカー検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Abcam PLC
• AdvaCare Pharma
• Bio-Diagnostics Ltd.
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Biopanda Reagents Ltd.
• CTK Biotech, Inc.
• DiaSorin S.p.A.
• F. Hoffmann-La Roche Ltd.
• Genome Diagnostics Pvt. Ltd.
• Hologic, Inc.
• InTec PRODUCTS, INC.
• Merck KGaA
• Meridian Bioscience, Inc. by SD Biosensor, Inc.
• Norgen Biotek Corporation
• QED Bioscience, Inc.
• Qiagen N.V.
• Quidel Corporation
• Rapid STD Testing by RSC Health, PA
• Teco Diagnostics
• Thermo Fisher Scientific, Inc.

LIST OF FIGURES

• FIGURE 1. HERPES MARKER TESTING MARKET RESEARCH PROCESS
• FIGURE 2. HERPES MARKER TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HERPES MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. HERPES MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. HERPES MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HERPES MARKER TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HERPES MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HERPES MARKER TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HSV-1, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HSV-2, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY ANTIBODY OR ANTIGEN-BASED KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION BASED KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY VIRAL CULTURE TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. CANADA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 28. CANADA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. CHINA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 45. CHINA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. INDIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. INDIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ITALY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 100. ITALY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. POLAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 112. POLAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. QATAR HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 115. QATAR HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. HERPES MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 145. HERPES MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Herpes Marker Testing Market was valued at USD 468.22 million in 2023, expected to reach USD 497.86 million in 2024, and is projected to grow at a CAGR of 6.46%, to USD 725.83 million by 2030.

Herpes marker testing is a crucial segment within the broader diagnostic testing market, focused on identifying and managing herpes simplex virus (HSV) infections through clinical assays that detect viral antigens or antibodies in biological samples. The necessity for herpes marker testing is driven by the high prevalence of HSV infections globally, the need for timely and accurate diagnosis for effective disease management, and the rising demand for personalized medicine. Applications range from routine diagnostic practices in healthcare facilities to research explorations aimed at understanding the virus's epidemiology and developing vaccines. End-users primarily include hospitals, diagnostic laboratories, and research institutions. Market growth is influenced by factors like advancements in molecular testing technologies, increasing awareness about sexually transmitted infections (STIs), and rising healthcare expenditure. However, challenges to growth include the high costs of advanced diagnostic systems, limited availability of point-of-care testing in low-resource regions, and social stigma associated with STIs hindering individuals from seeking diagnosis. Emerging opportunities lie in the expansion of testing services in developing regions with improving healthcare infrastructure and the ongoing R&D efforts to enhance test precision and reduce time-to-result. Companies can capitalize on the growing trend towards home-based testing kits and digital health platforms for remote diagnosis. However, regulatory scrutiny and the need for high specificity and sensitivity in test results remain critical barriers. Innovation in this space could focus on developing cost-effective, rapid-result test kits suitable for home use and integrating artificial intelligence for predictive diagnosis and personalized treatment plans. The market is dynamic with moderate to high competition, requiring strategic partnerships and continuous innovation for sustained growth. Overall, targeted investment in R&D, coupled with strategic market expansion strategies, will be key to capitalizing on future growth opportunities while navigating existing challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Herpes Marker Testing Market

The Herpes Marker Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of herpes infections among population
  • Growing awareness of early diagnosis and treatments of oral and genital infection
  • Rising healthcare spendings and improved healthcare infrastructure
• Market Restraints
  • Limited availability of laboratories along with lack of skilled personnel
• Market Opportunities
  • Introduction of newly developed herpes testing kits
  • Growing research activities for novel vaccines to treat herpes infections
• Market Challenges
  • Stringent and time consuming approval processes

Porter's Five Forces: A Strategic Tool for Navigating the Herpes Marker Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Herpes Marker Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Herpes Marker Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Herpes Marker Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Herpes Marker Testing Market

A detailed market share analysis in the Herpes Marker Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Herpes Marker Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Herpes Marker Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Herpes Marker Testing Market

A strategic analysis of the Herpes Marker Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Herpes Marker Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, AdvaCare Pharma, Bio-Diagnostics Ltd., Bio-Rad Laboratories, Inc., bioMerieux SA, Biopanda Reagents Ltd., CTK Biotech, Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Genome Diagnostics Pvt. Ltd., Hologic, Inc., InTec PRODUCTS, INC., Merck KGaA, Meridian Bioscience, Inc. by SD Biosensor, Inc., Norgen Biotek Corporation, QED Bioscience, Inc., Qiagen N.V., Quidel Corporation, Rapid STD Testing by RSC Health, PA, Teco Diagnostics, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Herpes Marker Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Indication, market is studied across HSV-1 and HSV-2.
• Based on Test Type, market is studied across Antibody or Antigen-based Kits, Nucleic Acid Amplification based Kits, and Viral Culture Test.
• Based on Application, market is studied across Clinical and Research.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of herpes infections among population
    • 5.1.1.2. Growing awareness of early diagnosis and treatments of oral and genital infection
    • 5.1.1.3. Rising healthcare spendings and improved healthcare infrastructure
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability of laboratories along with lack of skilled personnel
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of newly developed herpes testing kits
    • 5.1.3.2. Growing research activities for novel vaccines to treat herpes infections
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent and time consuming approval processes
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Herpes Marker Testing Market, by Indication

• 6.1. Introduction
• 6.2. HSV-1
• 6.3. HSV-2

7. Herpes Marker Testing Market, by Test Type

• 7.1. Introduction
• 7.2. Antibody or Antigen-based Kits
• 7.3. Nucleic Acid Amplification based Kits
• 7.4. Viral Culture Test

8. Herpes Marker Testing Market, by Application

• 8.1. Introduction
• 8.2. Clinical
• 8.3. Research

9. Americas Herpes Marker Testing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Herpes Marker Testing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Herpes Marker Testing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Abcam PLC
• 3. AdvaCare Pharma
• 4. Bio-Diagnostics Ltd.
• 5. Bio-Rad Laboratories, Inc.
• 6. bioMerieux SA
• 7. Biopanda Reagents Ltd.
• 8. CTK Biotech, Inc.
• 9. DiaSorin S.p.A.
• 10. F. Hoffmann-La Roche Ltd.
• 11. Genome Diagnostics Pvt. Ltd.
• 12. Hologic, Inc.
• 13. InTec PRODUCTS, INC.
• 14. Merck KGaA
• 15. Meridian Bioscience, Inc. by SD Biosensor, Inc.
• 16. Norgen Biotek Corporation
• 17. QED Bioscience, Inc.
• 18. Qiagen N.V.
• 19. Quidel Corporation
• 20. Rapid STD Testing by RSC Health, PA
• 21. Teco Diagnostics
• 22. Thermo Fisher Scientific, Inc.